FDA Drug Application (021284) for RITALIN LA by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021284
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRITALIN LA
Active IngredientMETHYLPHENIDATE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METHYLPHENIDATE HYDROCHLORIDE12


Back to FDA Applications sponsored by NOVARTIS